The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course

Although cytogenetic abnormalities are important prognostic factors in myeloid malignancies, they are not included in current prognostic scores for primary myelofibrosis (PMF). To determine their relevance in PMF, we retrospectively examined the impact of cytogenetic abnormalities and karyotypic evo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood
Egile Nagusiak: Tam, Constantine S., Abruzzo, Lynne V., Lin, Katherine I., Cortes, Jorge, Lynn, Alice, Keating, Michael J., Thomas, Deborah A., Pierce, Sherry, Kantarjian, Hagop, Verstovsek, Srdan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2009
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4828077/
https://ncbi.nlm.nih.gov/pubmed/19131547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-09-178541
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak